TFCP2L1 突变或致人类远端肾小管病新综合征
研究对 51 个超声肾脏回声增强且患 CKD 的家系行全外显子测序,在一名近亲婚配的阿拉伯患者中发现 TFCP2L1 纯合截短突变。该患者 2 月龄前即患 CKD,伴严重低氯低钠低钾性碱中毒、癫痫、发育迟缓、肌张力低下及白内障。功能实验提示该突变为功能丧失性,可能通过影响 TFCP2L1 二聚化导致远端肾小管病。
要点
- 早发 CKD 伴超声肾脏回声增强者应考虑单基因病因检测。
- TFCP2L1 纯合截短突变可表现为婴儿期 CKD 合并盐丢失性肾小管病。
- 该突变影响 TFCP2L1 与 UBP1 形成二聚体,损害转录活性。
核心结论
- TFCP2L1 功能丧失性突变可能是儿童 CKD 伴盐丢失性肾小管病的潜在新病因。
研究设计与样本
- 对 51 个超声肾脏回声增强且患 CKD 的家系行全外显子测序以寻找新单基因病因。
主要发现
- 在一名近亲婚配的阿拉伯患者中发现 TFCP2L1 纯合截短突变。
- 该患者 2 月龄前发生 CKD,并有严重低氯、低钠、低钾性碱中毒、癫痫、发育迟缓、肌张力低下和白内障。
- TFCP2L1 在整个肾脏发育中表达,尤其位于远端肾单位。
- TFCP2L1 可诱导大鼠间充质细胞来源的肾小管生长和发育。
- 患者突变对应的 TFCP2L1 cDNA 克隆不能与 UBP1 形成同源或异源二聚体。
临床怎么用
- 对婴儿期不明原因 CKD 伴盐丢失性肾小管病及 Extrarenal 表现者,可考虑 TFCP2L1 相关单基因病评估。
局限性
- 主要依据单一家系及功能实验,未提供突变人群频率或更大样本验证数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An underlying monogenic cause of early-onset chronic kidney disease (CKD) can be detected in ∼20% of individuals. For many etiologies of CKD manifesting before 25 years of age, >200 monogenic causative genes have been identified to date, leading to the elucidation of mechanisms of renal pathogenesis. METHODS: In 51 families with echogenic kidneys and CKD, we performed whole-exome sequencing to identify novel monogenic causes of CKD. RESULTS: We discovered a homozygous truncating mutation in the transcription factor gene transcription factor CP2-like 1 (TFCP2L1) in an Arabic patient of consanguineous descent. The patient developed CKD by the age of 2 months and had episodes of severe hypochloremic, hyponatremic and hypokalemic alkalosis, seizures, developmental delay and hypotonia together with cataracts. We found that TFCP2L1 was localized throughout kidney development particularly in the distal nephron. Interestingly, TFCP2L1 induced the growth and development of renal tubules from rat mesenchymal cells. Conversely, the deletion of TFCP2L1 in mice was previously shown to lead to reduced expression of renal cell markers including ion transporters and cell identity proteins expressed in different segments of the distal nephron. TFCP2L1 localized to the nucleus in HEK293T cells only upon coexpression with its paralog upstream-binding protein 1 (UBP1). A TFCP2L1 mutant complementary DNA (cDNA) clone that represented the patient's mutation failed to form homo- and heterodimers with UBP1, an essential step for its transcriptional activity. CONCLUSION: Here, we identified a loss-of-function TFCP2L1 mutation as a potential novel cause of CKD in childhood accompanied by a salt-losing tubulopathy.
引用
- Klämbt V, Werth M, Onuchic-Whitford AC, et al. Mutations in transcription factor CP2-like 1 may cause a novel syndrome with distal renal tubulopathy in humans. Nephrol Dial Transplant. 2021. PMID: 33097957. doi:10.1093/ndt/gfaa215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。